NCT01249443
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection treatment 1 terminated NCT06034964
Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC Not Available Not Available active_not_recruiting NCT02511821
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery No drug interventions device_feasibility Not Available completed NCT04670445
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 terminated NCT04221893
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers No drug interventions treatment Not Available recruiting NCT00061932
Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach treatment 2 completed NCT00991952
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT05856500
A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors No drug interventions treatment Not Available not_yet_recruiting NCT00064259
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer treatment 1 / 2 terminated NCT04267575
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites No drug interventions treatment Not Available unknown_status NCT04267549
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer treatment 2 active_not_recruiting NCT00103324
S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer treatment 2 completed NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer treatment 1 completed NCT03618758
Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 treatment 1 / 2 completed NCT03222258
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients No drug interventions Not Available Not Available completed NCT03368963
TAS102 in Combination With NAL-IRI in Advanced GI Cancers treatment 1 / 2 recruiting NCT05301465
Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab. No drug interventions Not Available Not Available unknown_status NCT00062374
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction treatment 2 completed NCT01846520
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers No drug interventions supportive_care Not Available completed NCT05204173
Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis treatment 2 unknown_status NCT06519591
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis treatment 2 recruiting NCT00089362
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors treatment 1 completed NCT00006389
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer treatment 2 completed NCT00982592
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer treatment 2 completed NCT03755440
PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. treatment 2 completed NCT02344810
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer treatment 1 / 2 withdrawn NCT00031681
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) treatment 1 completed NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer No drug interventions health_services_research Not Available unknown_status NCT01191684
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer treatment 1 completed NCT00397384
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer treatment 1 completed NCT04599179
SEMS and Gastroenterostomy No drug interventions Not Available Not Available completed NCT01637805
Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer No drug interventions supportive_care 1 unknown_status NCT02291211
S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis treatment 2 unknown_status NCT02890511
A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer treatment 1 / 2 completed NCT04592211
Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer With HRR Mutation and MSS treatment 1 / 2 unknown_status NCT02333188
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer treatment 1 completed NCT03159585
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors No drug interventions treatment 1 completed NCT01939275
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT04563975
Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric Cancer treatment 2 unknown_status NCT01643499
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies treatment 1 completed NCT01231399
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer treatment 1 / 2 completed NCT00084617
Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma treatment 2 completed NCT05319639
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab treatment 1 / 2 recruiting NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT04168931
Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC treatment 2 terminated NCT01839773
Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer treatment 3 completed NCT03701373
Maintenance Treatment With S-1 in Gastric Cancer Patients treatment 2 unknown_status NCT06342427
Stomach Cancer Exosome-based Detection No drug interventions Not Available Not Available completed NCT00607594
Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer treatment 2 completed NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT00068380
A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer treatment 2 completed NCT01178944
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer treatment 2 completed NCT01705340
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery treatment 1 terminated NCT00084604
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma treatment 2 completed NCT01612546
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery treatment 2 completed NCT06157892
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors treatment 1 / 2 recruiting NCT06585488
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants with Advanced or Metastatic Solid Tumors with KRAS Mutations or Amplification treatment 1 not_yet_recruiting NCT06592287
The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer treatment 1 / 2 not_yet_recruiting NCT01248403
A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy treatment 3 completed NCT02038621
The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer treatment 2 unknown_status NCT00845884
Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer treatment 1 / 2 unknown_status NCT03579784
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer treatment 2 active_not_recruiting NCT00879333
Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) treatment 3 completed NCT05028933
IMC001 for Clinical Research on Advanced Digestive System Malignancies No drug interventions treatment 1 recruiting NCT00854854
Efficacy Study of TKcell in Advanced Gastric Cancer treatment 1 / 2 unknown_status NCT01152853
PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer treatment 2 completed NCT03350477
Bioinformation Therapy for Gastric Cancer No drug interventions treatment 2 / 3 completed NCT06486545
Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer treatment Not Available not_yet_recruiting NCT01946061
A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer treatment 2 terminated NCT04286711
Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer treatment 1 / 2 unknown_status NCT03255811
Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer treatment Not Available unknown_status NCT06346093
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer No drug interventions treatment Not Available recruiting NCT03954756
Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer treatment 2 unknown_status NCT00565370
Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP treatment 1 / 2 completed NCT01471470
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer treatment 2 completed NCT01206218
Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer No drug interventions treatment 2 / 3 unknown_status NCT01047618
Venous Thromboembolism in Advanced Gastric Cancer Patients No drug interventions Not Available Not Available completed NCT02072317
Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer treatment 2 unknown_status NCT03564834
Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients No drug interventions treatment 2 unknown_status NCT00519324
Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer treatment 2 completed NCT05649163
Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy Not Available Not Available not_yet_recruiting NCT01015339
Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction treatment 3 unknown_status NCT03449966
Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy Status No drug interventions diagnostic Not Available unknown_status NCT01049620
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX treatment 1 completed NCT01042782
Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction treatment 1 completed NCT01136031
Paclitaxel and Irinotecan in Advanced Gastric Cancer treatment 1 / 2 completed NCT06376773
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. No drug interventions Not Available Not Available completed NCT00842491
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer treatment 2 completed NCT05076591
IMM2902, a HER2/SIRPα Bispecific mAb-Trap Antibody-receptor Fusion Protein, in Patients With HER2-expressing Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02952729
Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2 No drug interventions treatment 1 completed NCT04890392
Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC treatment 2 unknown_status NCT00842244
Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer treatment 1 completed NCT03137004
Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer treatment 2 unknown_status NCT01503372
FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer treatment 2 completed NCT01238055
Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer treatment 2 completed NCT02071043
Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis treatment 2 completed NCT00821990
Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer No drug interventions treatment 3 completed NCT00743964
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) treatment 2 completed NCT04195828
Camrelizumab Combined With Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer treatment 2 active_not_recruiting NCT02123407
Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer No drug interventions treatment 3 unknown_status NCT02451956
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy treatment 2 completed NCT03609359
Lenvatinib and Pembrolizumab Simultaneous Combination Study treatment 2 completed NCT06432075
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer No drug interventions treatment 0 not_yet_recruiting NCT00992199
Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer prevention 2 unknown_status NCT01441336
Laparoscopic Gastrectomy for Advanced Gastric Cancer No drug interventions treatment 2 completed NCT01851941
A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer treatment 2 completed NCT04385641
Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer No drug interventions treatment Not Available unknown_status NCT02935634
A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer treatment 2 completed NCT04182724
Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer treatment 1 / 2 unknown_status NCT03393416
A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor treatment 1 unknown_status NCT02142322
Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer No drug interventions treatment 2 completed NCT01084330
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer treatment 2 completed NCT04799548
A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma treatment 2 recruiting NCT02873520
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer No drug interventions treatment 1 / 2 unknown_status NCT00428220
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. treatment Not Available completed NCT00915382
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS treatment 3 completed NCT03223376
A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA) treatment 3 unknown_status NCT05584592
A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients No drug interventions other Not Available recruiting NCT03286244
Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer treatment 1 unknown_status NCT02560740
A Study of the Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy No drug interventions prevention Not Available terminated NCT01402401
Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients treatment 2 terminated NCT00976768
Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin treatment 2 completed NCT06169410
Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer treatment 4 recruiting NCT03554395
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer No drug interventions treatment 2 withdrawn NCT01472250
A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China No drug interventions Not Available Not Available completed NCT04797923
A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination treatment 2 unknown_status